RS50229B - Analozi vitamina d3 - Google Patents

Analozi vitamina d3

Info

Publication number
RS50229B
RS50229B YU92701A YUP92701A RS50229B RS 50229 B RS50229 B RS 50229B YU 92701 A YU92701 A YU 92701A YU P92701 A YUP92701 A YU P92701A RS 50229 B RS50229 B RS 50229B
Authority
RS
Serbia
Prior art keywords
alkyl
denotes
analogs
vitamin
fluoro
Prior art date
Application number
YU92701A
Other languages
English (en)
Inventor
Andrew David Batcho
Bernard Michael Hennessy
Milan Radoje Uskokovic
Original Assignee
F. Hoffmann-La Roche Ag.,
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by F. Hoffmann-La Roche Ag., filed Critical F. Hoffmann-La Roche Ag.,
Publication of YU92701A publication Critical patent/YU92701A/sh
Publication of RS50229B publication Critical patent/RS50229B/sr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C401/00—Irradiation products of cholesterol or its derivatives; Vitamin D derivatives, 9,10-seco cyclopenta[a]phenanthrene or analogues obtained by chemical preparation without irradiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/08—Drugs for disorders of the urinary system of the prostate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/28—Antiandrogens

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Oncology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Jedinjenje opšte formule u kojoj R1 označava vodonik ili C1-C4-alkil-grupu, R2 označava vodonik ili C1-C4-alkil-grupu ili R1, R2 i C20 zajedno označavaju ciklopropil, A označava R3 označava C1-C4-alkil, hidroksi-C1-C4-alkil ili fluor-C1-C4-alkil i R4 označava C1-C4-alkil, hidroksi-C1-C4-alkil ili fluor-C1-C4-alkil. Prijava sadrži još 6 patentnih zahteva.
YU92701A 1999-07-12 2000-07-06 Analozi vitamina d3 RS50229B (sr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US14341399P 1999-07-12 1999-07-12

Publications (2)

Publication Number Publication Date
YU92701A YU92701A (sh) 2004-09-03
RS50229B true RS50229B (sr) 2009-07-15

Family

ID=22503954

Family Applications (1)

Application Number Title Priority Date Filing Date
YU92701A RS50229B (sr) 1999-07-12 2000-07-06 Analozi vitamina d3

Country Status (36)

Country Link
US (1) US6331642B1 (sr)
EP (1) EP1200399B1 (sr)
JP (1) JP3803579B2 (sr)
KR (1) KR100477161B1 (sr)
CN (1) CN1174964C (sr)
AR (1) AR024695A1 (sr)
AT (1) ATE262508T1 (sr)
AU (1) AU779408B2 (sr)
BR (1) BR0012419A (sr)
CA (1) CA2378803C (sr)
CO (1) CO5190683A1 (sr)
DE (1) DE60009303T2 (sr)
DK (1) DK1200399T3 (sr)
EG (1) EG23909A (sr)
ES (1) ES2215707T3 (sr)
GC (1) GC0000198A (sr)
HK (1) HK1047578B (sr)
HR (1) HRP20020007A2 (sr)
HU (1) HUP0202157A3 (sr)
IL (2) IL147254A0 (sr)
JO (1) JO2255B1 (sr)
MA (1) MA26808A1 (sr)
MX (1) MXPA02000313A (sr)
MY (1) MY122633A (sr)
NO (1) NO20020161L (sr)
NZ (1) NZ516339A (sr)
PE (1) PE20010328A1 (sr)
PL (1) PL201877B1 (sr)
PT (1) PT1200399E (sr)
RS (1) RS50229B (sr)
RU (1) RU2235721C2 (sr)
TR (1) TR200200054T2 (sr)
TW (1) TWI268276B (sr)
UY (1) UY26239A1 (sr)
WO (1) WO2001004089A1 (sr)
ZA (1) ZA200110487B (sr)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2001278744A1 (en) * 2000-08-17 2002-02-25 Chugai Seiyaku Kabushiki Kaisha Remedial agent for osteoporosis
CA2424555A1 (en) 2000-10-02 2002-04-11 Emory University Triptolide analogs for the treatment of autoimmune and inflammatory disorders
CN1285573C (zh) * 2001-09-21 2006-11-22 霍夫曼-拉罗奇有限公司 3－脱氧－维生素d3类似物酯
US7563810B2 (en) 2002-11-06 2009-07-21 Celgene Corporation Methods of using 3-(4-amino-1-oxo-1,3-dihydroisoindol-2-yl)-piperidine-2,6-dione for the treatment and management of myeloproliferative diseases
US8034831B2 (en) 2002-11-06 2011-10-11 Celgene Corporation Methods for the treatment and management of myeloproliferative diseases using 4-(amino)-2-(2,6-Dioxo(3-piperidyl)-isoindoline-1,3-dione in combination with other therapies
CA2524026A1 (en) * 2003-04-30 2004-11-18 Bioxell S.P.A. Gemini vitamin d3 compounds and methods of use thereof
US20050113348A1 (en) * 2003-06-12 2005-05-26 Yanchun Li Vitamin D and vitamin D analogs or derivatives as new anti-hypertensive agents
GB2407499B (en) * 2003-11-03 2008-02-27 Bioxell Spa Vitamin D3 analogue for use in the treatment of BPH
AU2004275845A1 (en) * 2003-09-24 2005-04-07 Bioxell, S.P.A. Methods for treating bladder dysfunction
US7332482B2 (en) * 2003-09-24 2008-02-19 Bioxell S.P.A. Method for treating benign prostatic hyperplasia
US8404667B2 (en) * 2006-12-29 2013-03-26 Wisconsin Alumni Research Foundation Compounds, compositions, kits and methods of use to orally and topically treat acne and other skin conditions by 19-Nor vitamin D analog
AU2005289664A1 (en) * 2004-09-24 2006-04-06 Bioxell S.P.A. 20-cycloalkyl,26,27-alkyl/haloalkyl vitamin D3 compounds and methods of use thereof
JP2008519808A (ja) 2004-11-12 2008-06-12 ビオエクセル エスピーエー 膀胱癌治療のためのビタミンｄ誘導体及び抗増殖薬の併用
US20100009949A1 (en) * 2006-03-24 2010-01-14 Bioxell S.P.A. Novel method
CN101754971A (zh) * 2007-05-30 2010-06-23 赛特克罗公司 氧化膦维生素d前体的制备方法
LT2708559T (lt) 2008-04-11 2018-06-11 Chugai Seiyaku Kabushiki Kaisha Antigeną surišanti molekulė, galinti pakartotinai prisijungti prie dviejų ar daugiau antigeno molekulių
EP2682386B1 (en) * 2011-03-02 2016-08-17 Nihon University Novel vitamin d receptor modulator with partial agonist activity
KR102523660B1 (ko) 2016-09-26 2023-04-19 (주)하이플 박스용 테두리 부재보강부재와 에셈블리컨테이너 원터치크립이 포함된 박스

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4749710A (en) 1985-05-01 1988-06-07 Hoffmann-La Roche Inc. Immunosuppressive agents
ZA8923B (en) * 1988-01-20 1989-09-27 Hoffmann La Roche 16-dehydro-vitamin d3-derivatives
US5087619A (en) * 1988-01-20 1992-02-11 Hoffman-La Roche Inc. Vitamin D3 analogs
CA2096105A1 (en) * 1992-10-07 1994-04-08 Enrico Giuseppe Baggiolini (Deceased) Vitamin d3 fluorinated analogs
US5401733A (en) * 1993-10-01 1995-03-28 Hoffmann-La Roche Inc. Stable and active metabolites of 1,25-dihydroxy-16-ene-cholecalciferol
US5428029A (en) * 1993-11-24 1995-06-27 Hoffmann-La Roche Inc. Vitamin D3 fluorinated analogs
US6040300A (en) * 1995-04-07 2000-03-21 Arch Development Corporation Method of preventing colon cancer with vitamin D3 analogues
AU708679B2 (en) 1996-03-21 1999-08-12 F. Hoffmann-La Roche Ag 1,25-dihydroxy-16,22,23-trisdehydro-cholecalciferol derivatives

Also Published As

Publication number Publication date
CO5190683A1 (es) 2002-08-29
JP2003504354A (ja) 2003-02-04
AU6689400A (en) 2001-01-30
JO2255B1 (en) 2004-10-07
MXPA02000313A (es) 2002-06-21
NO20020161D0 (no) 2002-01-11
PE20010328A1 (es) 2001-03-22
DE60009303D1 (de) 2004-04-29
US6331642B1 (en) 2001-12-18
EP1200399B1 (en) 2004-03-24
GC0000198A (en) 2006-03-29
IL147254A (en) 2006-07-05
KR20020033728A (ko) 2002-05-07
AU779408B2 (en) 2005-01-20
HK1047578A1 (en) 2003-02-28
AR024695A1 (es) 2002-10-23
KR100477161B1 (ko) 2005-03-18
WO2001004089A1 (en) 2001-01-18
TR200200054T2 (tr) 2002-06-21
PT1200399E (pt) 2004-06-30
JP3803579B2 (ja) 2006-08-02
RU2235721C2 (ru) 2004-09-10
MY122633A (en) 2006-04-29
ZA200110487B (en) 2003-03-20
HRP20020007A2 (en) 2003-04-30
IL147254A0 (en) 2002-08-14
ATE262508T1 (de) 2004-04-15
HUP0202157A3 (en) 2004-04-28
HUP0202157A2 (en) 2002-10-28
BR0012419A (pt) 2002-03-26
DE60009303T2 (de) 2005-02-24
DK1200399T3 (da) 2004-07-19
ES2215707T3 (es) 2004-10-16
CN1360572A (zh) 2002-07-24
UY26239A1 (es) 2000-10-31
EP1200399A1 (en) 2002-05-02
CA2378803C (en) 2009-01-27
PL356124A1 (en) 2004-06-14
CA2378803A1 (en) 2001-01-18
NZ516339A (en) 2003-07-25
CN1174964C (zh) 2004-11-10
EG23909A (en) 2007-12-30
MA26808A1 (fr) 2004-12-20
HK1047578B (zh) 2005-04-29
PL201877B1 (pl) 2009-05-29
NO20020161L (no) 2002-01-11
YU92701A (sh) 2004-09-03
TWI268276B (en) 2006-12-11

Similar Documents

Publication Publication Date Title
RS50229B (sr) Analozi vitamina d3
HRP20030383B1 (en) Lactam compound
AP2002002637A0 (en) Novel piperazine
PT1413582E (pt) Pirrolobenzodiazepinas dimericas
DE60012188D1 (de) Fungizide
RS50140B (sr) Postupak za dobijanje perkihinina i njegova upotreba
RS49673B (sr) Inhibitori sintaze azot-monoksida
BR0114045A (pt) Poliarilcarboxamidas úteis como agentes redutores de lipìdeos
DK1385515T3 (da) Spiropyrazole forbindelser
RS53428B (sr) Kompozicije i antivirusna aktivnost supstituisanih azaindoloksosirćetnih piperazin derivata
SE0004245D0 (sv) Novel compounds and their use
HK1045990A1 (en) Novel derivatives and analogues of galanthamin.
TR200201128T2 (tr) PDE4 inhibitörleri olarak tetrahidrotiyopiranfitalazinon türevleri.
WO2002000638A3 (en) Substituted phthalides as anti-convulsive drugs
AP2001002188A0 (en) 5HT1 antagonists for antidepressant therapy.
RS50002B (sr) Eletriptan hidrobromid monohidrat
BR9902084A (pt) Heterociclos.
DK1204659T3 (da) Serotonerge benzofuraner
DK1204658T3 (da) Benzofurylpiperazin-serotoninagonister
DE60005517D1 (de) Kaliumkanal-blockierende mittel
DE60121048D1 (de) PYRAZINOi1'2':1,6öPYRIDOi3,4-BöINDOLDERIVATE
HRP20010885B1 (en) Ethanesulfonyl-piperidine derivatives
DE60216948D1 (en) 4'-methansulfonylbiphenylderivate als hochselektive cyclooxygenase-2-inhibitoren
AR027349A1 (es) Derivados de amidas heterociclicas
DE69827614D1 (de) Chinoxalindionen